Onset Therapeutics Announces Launch of Optase(TM), a Novel Wound Care Product.WOONSOCKET, R.I. -- Onset Therapeutics, a specialty pharmaceutical company that focuses on the development and commercialization of innovative treatments for skin and wound related disorders, announced today that they have launched Optase (TM), the first in a series of prescription products expected to be introduced to the rapidly growing wound care market. Optase (TM) will be targeted primarily to the long term care market (e.g. Nursing Homes) and acute wound care clinics. Optase(TM) (Trypsin trypsin, enzyme that acts to degrade protein; it is often referred to as a proteolytic enzyme, or proteinase. Trypsin is one of the three principal digestive proteinases, the other two being pepsin and chymotrypsin. , Balsam of Peru balsam of Peru, n Latin names: Myroxylon balsamum, Myroxylon pereirae; parts used: oleo-resin, essential oil; uses: (suppositories) hemorrhoids, (internally) cough, respiratory illnesses, burns, fever, scabies (topical), circulation booster, , Castor Oil castor oil, yellowish oil obtained from the seed of the castor bean. The oil content of the seeds varies from about 20% to 50%. After the hulls are removed the seeds are cold-pressed. ) is a prescription product formulated in a patent pending Gel delivery system for topical application on a wide variety of wounds. It is indicated to promote healing in the treatment of pressure ulcers, venous and arterial ulcers and dehiscent de·his·cence n. 1. Botany The spontaneous opening at maturity of a plant structure, such as a fruit, anther, or sporangium, to release its contents. 2. wounds. Optase(TM) was created by a team of scientists to specifically address some of the limitations inherent in currently available wound care formulations. "Sub-optimal physical properties can reduce the therapeutic benefit of a formulation's active ingredients. The physical properties of the Optase(TM) formulation were specifically tailored to maximize the therapeutic benefit of the product," stated Mark Trumbore, PhD, Project Manager, Scientific Affairs. Optase's Gel formulation acts as an effective capillary bed capillary bed n. The capillaries of the blood system considered collectively with their volume capacity. Capillary bed A dense network of tiny blood vessels that enables blood to fill a tissue or organ. stimulant to promote wound healing wound healing Physiology The repair of a wound Steps Inflammation, repair and closure, remodeling, final healing; repair of incisions may be either simple–'clean' wounds with little loss of tissue heal by 'primary intention', or 'dirty' wounds heal by , while serving as an occlusive occlusive /oc·clu·sive/ (o-kloo´siv) pertaining to or causing occlusion. oc·clu·sive adj. 1. Occluding or tending to occlude. 2. barrier to protect the wound site. Optase's clear, easy-to-spread formulation permits wound visualization, minimizes wound bed disruption during application, and eliminates the need for secondary dressings, saving time and money. The product will be promoted initially by a team of 27 field sales representatives that call on target accounts nationwide, through a partnership with AciesHealth. The product is currently available through all major drug wholesalers. "We are very excited to be able to deliver a revolutionary product that provides so many benefits to the wound care market," states Michael Heffernan Michael Heffernan (3 April, 1885 – 21 November, 1970) was an Irish Farmers' Party politician. He was first elected to Dáil Éireann in 1927 as a TD for Tipperary. He served as Parliamentary Secretary to the Minister for Posts and Telegraphs from 1927 to 1932. , President of Onset Therapeutics. "Our goal was to develop an optimized formulation that addressed the demands and challenges of difficult to heal wounds, and the needs of the wound care professional. We have a full pipeline of products in development that are targeted to the wound care market and expect to launch two additional wound care products in 2006." In addition to wound care, Onset Therapeutics also focuses on skin related disorders and anticipates launching three dermatology products that incorporate its novel Foam Vehicle Technology in 2006. These products will be promoted by a dermatology field salesforce. About Onset Therapeutics Onset Therapeutics, is a privately held specialty pharmaceutical company focusing on the development and commercialization of novel, patent protected topical products for the treatment of wounds and skin disorders. The company's capabilities include Formulation Development, Intellectual Property Development; Clinical Development; GMP GMP (guanosine monophosphate): see guanine. Manufacturing; and Product Commercialization. For more information, please visit the company's website at www.onsettx.com About AciesHealth AciesHealth is a Bellefonte, Pennsylvania Bellefonte is a borough in Centre County, Pennsylvania, United States. It is part of the State College, Pennsylvania Metropolitan Statistical Area. The population was 6,395 at the 2000 census. It is the county seat of Centre County. full line burn and wound care products and services provider. Committed to excellence, AciesHealth works closely with healthcare professionals to provide them with the products and services they need to care for their patients. For more information, please visit the company's website at www.acieshealth.com |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion